MERLI, MICHELE
 Distribuzione geografica
Continente #
NA - Nord America 559
EU - Europa 407
AS - Asia 287
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 1.255
Nazione #
US - Stati Uniti d'America 553
CN - Cina 263
IE - Irlanda 202
FI - Finlandia 60
UA - Ucraina 35
DE - Germania 29
IT - Italia 25
IN - India 21
SE - Svezia 19
BE - Belgio 13
GB - Regno Unito 11
FR - Francia 9
CA - Canada 6
RU - Federazione Russa 2
TR - Turchia 2
AU - Australia 1
EU - Europa 1
GR - Grecia 1
ID - Indonesia 1
RO - Romania 1
Totale 1.255
Città #
Dublin 199
Chandler 151
Nanjing 71
Jacksonville 64
Beijing 51
Ashburn 42
Nanchang 31
Ann Arbor 26
Princeton 25
Wilmington 25
Helsinki 24
Lawrence 24
Changsha 23
Pune 20
Medford 16
Shenyang 16
Hebei 15
Jiaxing 14
New York 14
Brussels 13
Shanghai 12
Tianjin 12
Milan 9
Boardman 8
Woodbridge 8
Pavia 7
Hangzhou 4
Norwalk 4
Toronto 4
Cork 3
Fairfield 2
Falkenstein 2
Houston 2
Jinan 2
Ningbo 2
San Francisco 2
Seattle 2
Washington 2
Zhengzhou 2
Athens 1
Auburn Hills 1
Baotou 1
Canberra 1
Dearborn 1
Des Moines 1
Guangzhou 1
Kunming 1
Lanzhou 1
Markham 1
Monmouth Junction 1
Redwood City 1
Saint Petersburg 1
San Jose 1
Targu 1
Tomsk 1
Verona 1
Wuhan 1
Totale 971
Nome #
Subcutaneous 'lipoma-like' B-cell lymphoma associated with HCV infection: a new presentation of primary extranodal marginal zone B-cell lymphoma of MALT. 93
High resolution genome-wide array-comparative genomic hybridization in splenic marginal zone B-cell lymphoma 72
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometry. 71
Stereotyped patterns of B-cell receptor in splenic marginal zone lymphoma. 64
Distinctive clinical and histological features of Waldenström's macroglobulinemia and splenic marginal zone lymphoma. 64
Bayesian models identify specific lymphoproliferative disorders associated with hepatitis C virus infection 63
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms 56
Central nervous system relapse occurs in about 5% of cases of acute promyelocytic leukaemia 56
Indolent B-cell lymphomas associated with HCV infection: clinical and virological features and role of antiviral therapy 55
Investigational therapies targeting lymphocyte antigens for the treatment of non-Hodgkin's lymphoma 55
The use of anthracycline at first-line compared to alkylating agents or nucleoside analogs improves the outcome of salvage treatments after relapse in follicular lymphoma The REFOLL study by the Fondazione Italiana Linfomi. 53
Everolimus in diffuse large B-cell lymphomas 52
Antiviral therapies for managing viral hepatitis in lymphoma patients 51
Direct-acting Antivirals during or after Immuno-chemotherapy in Hepatitis C Virus-positive Diffuse Large B-cell Lymphomas 51
Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi. 50
Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection 50
The NOTCH pathway is recurrently mutated in diffuse large B cell lymphoma associated with hepatitis C virus infection. 49
Value of cytogenetic abnormalities in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a study of the MYSEC project. 46
Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients 45
Splenic marginal zone lymphoma: clinical clustering of immunoglobulin heavy chain repertoires 45
Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders 34
Impact of bone marrow fibrosis grade in post-polycythemia vera and post-essential thrombocythemia myelofibrosis: A study of the MYSEC group. 33
Gender effect on phenotype and genotype in patients with post-polycythemia vera and post-essential thrombocythemia myelofibrosis: results from the MYSEC project. 29
null 21
Rituximab maintenance in follicular lymphoma patients 19
Role of Rituximab Addition to First-line Chemotherapy Regimens in Nodular Lymphocyte-predominant Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi 17
Pre-Treatment with Bendamustine Does Not Affect Stem Cell Mobilization in Patients with Indolent Non-Hodgkin Lymphomas: A Multicenter Study on Behalf of the Fondazione Italiana Linfomi 9
T-Cells Subsets in Castleman Disease: Analysis of 28 Cases Including Unicentric, Multicentric and HHV8-Related Clinical Forms 7
Biological features and outcome of diffuse large B-cell lymphoma associated with hepatitis C virus in elderly patients: Results of the prospective 'Elderly Project' by the Fondazione Italiana Linfomi 4
Totale 1.314
Categoria #
all - tutte 4.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.468


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20199 0 0 0 0 0 0 0 0 7 0 1 1
2019/2020288 78 110 0 7 1 7 6 14 6 43 15 1
2020/2021104 10 7 2 8 7 8 1 20 15 14 9 3
2021/2022103 3 2 4 0 5 1 0 9 4 1 16 58
2022/2023469 37 44 5 26 43 37 1 20 228 2 16 10
2023/2024181 19 40 11 14 17 62 4 14 0 0 0 0
Totale 1.314